Patient Information Leaflet
Amitriptyline Hydrochloride Neuraxpharm 75 mg Film-Coated Tablets EFG
Read this leaflet carefully before you start taking this medicine because it contains important information for you.
Contents of the pack
Amitriptyline belongs to a group of medicines called tricyclic antidepressants.
This medicine is used to treat:
Do not take Amitriptyline Hydrochloride Neuraxpharm:
If you are taking amitriptyline, you must stop treatment with this medicine and wait 14 days before starting treatment with an MAOI.
This medicine must not be used in children under 6 years of age.
Warnings and precautions
Consult your doctor or pharmacist before starting treatment with Amitriptyline Hydrochloride Neuraxpharm.
Heart rhythm disorders and hypotension may occur if you receive a high dose of amitriptyline. This can also occur with usual doses if you have pre-existing heart disease.
Prolonged QT interval
A heart problem called "prolonged QT interval" (which appears on the electrocardiogram [ECG]) and heart rhythm disorders (fast or irregular heartbeat) have been reported with this medicine. Tell your doctor if:
Suicidal thoughts and worsening of depression
If you are depressed, you may sometimes think about harming yourself or taking your own life. This type of thought may increase when you first start taking antidepressants, as all these medicines take time to work, usually about two weeks, but sometimes longer.
You are more likely to have these thoughts:
If you have thoughts of harming yourself or taking your own life, contact your doctor or go to a hospital immediately.
It may be helpful to tell a relative or close friend that you are depressed and ask them to read this leaflet. You can ask them to tell you if they think your depression or anxiety is getting worse, or if they are worried about changes in your behavior.
Manic episodes
Some patients with manic-depressive illness may enter a manic phase, characterized by rapid, profuse ideas, excessive joy, and excessive physical activity. In these cases, it is essential to contact your doctor, who will probably change your medication.
Tell your doctor if you have or have had any medical problem, especially if you have
If you are taking antidepressants such as selective serotonin reuptake inhibitors (SSRIs), your doctor may consider changing the dose of your medication (see also section 2 "Other medicines and Amitriptyline Hydrochloride Neuraxpharm" and section 3).
Severe skin reactions, including drug reaction with eosinophilia and systemic symptoms (DRESS), have been reported in association with treatment with Amitriptyline Hydrochloride Neuraxpharm. Stop using Amitriptyline Hydrochloride Neuraxpharm and seek medical attention immediately if you notice any of the symptoms related to these severe skin reactions described in section 4.
Elderly people are more likely to experience certain side effects, such as dizziness when standing up due to low blood pressure (see also section 4 "Possible side effects").
Children and adolescents
Depression, neuropathic pain, prevention of chronic tension-type headache, and prevention of migraine.
Do not give this medicine to children and adolescents under 18 years of age for these treatments, as long-term safety and efficacy have not been established for this age group.
Nocturnal enuresis
Other medicines and Amitriptyline Hydrochloride Neuraxpharm
Some medicines may affect the way other medicines work and this can sometimes cause serious side effects.
Tell your doctor or pharmacist if you are taking or have recently taken any other medicines, such as:
You should also tell your doctor if you are taking or have recently taken medicines that may affect your heart rhythm, such as:
If you are going to have surgery and receive general or local anesthetics, you must tell your doctor that you are taking this medicine.
Also, tell your dentist that you are taking this medicine if you are going to receive a local anesthetic.
Taking Amitriptyline Hydrochloride Neuraxpharm with alcohol
It is not recommended to drink alcohol during treatment with this medicine, as it may increase its sedative effect.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor for advice before taking this medicine.
Amitriptyline is not recommended during pregnancy unless your doctor considers it clearly necessary and only after careful consideration of the benefits and risks. If you have taken this medicine during the last part of your pregnancy, the newborn may experience withdrawal symptoms such as irritability, increased muscle tone, tremor, irregular breathing, poor sucking, loud crying, urinary retention, and constipation.
Your doctor will advise you whether to start/continue/stop breastfeeding or stop using this medicine, taking into account the benefit of breastfeeding for the child and the benefit of treatment for you.
Driving and using machines
This medicine may cause drowsiness and dizziness, especially at the start of treatment. Do not drive or work with tools or machinery if you are affected.
Amitriptyline Hydrochloride Neuraxpharm contains lactose.
If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.
This medicine contains less than 23 mg of sodium (1 mmol) per tablet; this is essentially "sodium-free".
Follow your doctor's administration instructions for this medication exactly. If in doubt, consult your doctor again.
Not all dosage guidelines can be achieved with all pharmaceutical forms/concentrations. The appropriate pharmaceutical form/concentration should be selected for initial doses and for any subsequent dose increases.
Depression
Adults
The recommended initial dose is 25 mg twice a day.
Depending on the response to the medication, your doctor may gradually increase the dose to 150 mg per day divided into two doses.
Elderly patients (over 65 years) and patients with cardiovascular disease
The recommended initial dose is 10-25 mg per day.
Depending on your response to the medication, your doctor may gradually increase the dose to a total daily dose of 100 mg divided into two doses. If you receive doses of 100 mg - 150 mg, your doctor may need to perform more frequent follow-ups.
Use in children and adolescents
This medication should not be administered to children or adolescents for the treatment of depression. For more information, see section 2.
Neuropathic pain, chronic tension-type headache, and migraine prevention
Your doctor will adjust the medication based on your symptoms and response to treatment.
Adults
The recommended initial dose is 10 mg - 25 mg at night.
The recommended daily dose is 25 mg - 75 mg.
Depending on your response to the medication, your doctor may gradually increase the dose. If you are administered a dose greater than 100 mg per day, your doctor may need to perform more frequent follow-ups. Your doctor will indicate whether you should take the dose once a day or divide it into two doses.
Elderly patients (over 65 years) and patients with cardiovascular disease
The recommended initial dose is 10 mg - 25 mg at night.
Depending on your response to the medication, your doctor may gradually increase the dose. If you receive doses greater than 75 mg per day, your doctor may need to perform more frequent follow-ups.
Use in children and adolescents
This medication should not be administered to children or adolescents for the treatment of neuropathic pain, prevention of chronic tension-type headache, or migraine prophylaxis. For more information, see section 2.
Nocturnal enuresis
Use in children and adolescents
Recommended doses for children:
The dose should be gradually increased.
Take this medication 1 hour to 1 hour and a half before bedtime.
Before starting treatment, your doctor will perform an ECG to check for any signs of unusual heartbeats.
Your doctor will reevaluate your treatment after 3 months and, if necessary, perform another ECG.
Do not interrupt treatment without consulting your doctor first.
Patients with special risks
Patients with liver disease or those with a "deficient metabolism" usually receive lower doses.
Your doctor may take blood samples to determine the level of amitriptilina in your blood (see also section 2).
How and when to take Amitriptilina hidrocloruro Neuraxpharm
This medication should be taken orally.
The tablets can be taken with or without food.
Swallow the tablets with a glass of water. Do not chew them.
They are divisible tablets with 2 notches that facilitate breaking the tablet into 3 equal doses. Those doses that are not needed can be stored until the next administration.
Duration of treatment
Do not change the dose of the medication or interrupt treatment without consulting your doctor first.
Depression
As with other medications for the treatment of depression, it may take a few weeks to notice an improvement.
In depression, the duration of treatment is individual and usually lasts a minimum of 6 months. Your doctor will decide the duration of treatment.
Continue taking this medication for as long as your doctor recommends.
The underlying disease may persist for a long time. If you interrupt treatment too soon, symptoms may reappear.
Neuropathic pain, chronic tension-type headache, and migraine prevention
It may take a few weeks to notice an improvement in pain.
Talk to your doctor about the duration of treatment and continue taking this medication for as long as your doctor recommends.
Nocturnal enuresis
Your doctor will evaluate whether to continue treatment after 3 months.
If you take more Amitriptilina hidrocloruro Neuraxpharm than you should
Contact your doctor or the emergency department of the nearest hospital immediately. Do this even if you do not have any signs of discomfort or poisoning. Bring the packaging of this medication with you if you go to the doctor or hospital.
In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
Among the symptoms of overdose are:
If you forget to take Amitriptilina hidrocloruro Neuraxpharm
Take the next dose at the usual time. Do not take a double dose to make up for forgotten doses.
If you interrupt treatment with Amitriptilina hidrocloruro Neuraxpharm
Your doctor will decide when and how to interrupt treatment to avoid any unpleasant symptoms that may occur if treatment is interrupted abruptly (e.g., headache, feeling of discomfort, insomnia, and irritability).
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause adverse effects, although not everyone will experience them.
If you notice any of the following symptoms, you should go to your doctor immediately:
You should have an eye examination immediately before being able to continue treatment with this medication. These symptoms can be a sign of acute glaucoma. Very rare adverse effect, may affect up to 1 in 10,000 people.
These symptoms may be due to paralysis of parts of the intestine. Rare adverse effect, may affect up to 1 in 1,000 people.
It is possible that your liver is affected. Rare adverse effect, may affect up to 1 in 1,000 people.
These symptoms can be the first signs of a possible effect on the blood or bone marrow.
Blood effects can be a decrease in the number of red blood cells (which carry oxygen throughout the body), white blood cells (which help fight infections), and platelets (which help with blood clotting). Rare adverse effect, may affect up to 1 in 1,000 people.
Stop using Amitriptilina hidrocloruro Neuraxpharm and seek medical attention immediately if you notice any of the following symptoms:
The following adverse effects have been reported in the following frequencies:
Very frequent: may affect more than 1 in 10 people
Frequent: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people
Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known (cannot be estimated from available data)
An increased risk of bone fractures has been observed in patients treated with this type of medication.
Reporting of adverse effects
If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: www.notificaram.es.
By reporting adverse effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of sight and reach of children.
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
This medication does not require any special storage temperature.
Keep it in the original packaging to protect it from light.
Medications should not be thrown away in drains or trash. Deposit the packaging and medications you no longer need in the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This way, you will help protect the environment.
Composition of Amitriptilina hidrocloruro Neuraxpharm
The active substance is amitriptilina.
Core of the tablet: lactose monohydrate, pregelatinized corn starch, povidone K25, microcrystalline cellulose, sodium croscarmellose, anhydrous colloidal silica, magnesium stearate
Coating of the tablet: polyvinyl alcohol, titanium dioxide (E171), macrogol 4000, talc.
Appearance of the product and package contents
Amitriptilina hidrocloruro Neuraxpharm 75 mg are film-coated oblong tablets, white in color with two notches on both sides. The tablet can be divided into 3 equal doses.
The tablets are packaged in blisters and cardboard boxes containing 20, 30, 50, or 100 tablets.
Only some package sizes may be marketed.
Marketing authorization holder and manufacturer
Marketing authorization holder
Neuraxpharm, Spain, S.L.U.
Avda. Barcelona, 69
08970 Sant Joan Despí – Barcelona
Spain
Manufacturer
Neuraxpharm Arzneimittel GmbH
Elisabeth-Selbert-Str. 23, 40764 Langenfeld
Germany
or
Dragenopharm Apotheker Pueschl GmbH
Goellstr. 1, 84529 Tittmoning
Germany
Date of the last revision of this leaflet:January 2025.
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.